Does SUNITINIB MALATE Cause Second primary malignancy? 244 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Second primary malignancy have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 1.1% of all adverse event reports for SUNITINIB MALATE.
244
Reports of Second primary malignancy with SUNITINIB MALATE
1.1%
of all SUNITINIB MALATE reports
35
Deaths
71
Hospitalizations
How Dangerous Is Second primary malignancy From SUNITINIB MALATE?
Of the 244 reports, 35 (14.3%) resulted in death, 71 (29.1%) required hospitalization, and 11 (4.5%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB MALATE. However, 244 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB MALATE Cause?
Death (4,385)
Diarrhoea (3,044)
Fatigue (2,865)
Nausea (2,032)
Neoplasm progression (1,920)
Disease progression (1,745)
Decreased appetite (1,676)
Asthenia (1,651)
Vomiting (1,331)
Dysgeusia (1,226)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which SUNITINIB MALATE Alternatives Have Lower Second primary malignancy Risk?
SUNITINIB MALATE vs SUTENT
SUNITINIB MALATE vs SUTIMLIMAB-JOME
SUNITINIB MALATE vs SUVOREXANT
SUNITINIB MALATE vs SUZETRIGINE
SUNITINIB MALATE vs SYMBICORT